Bio-Rad Laboratories (BIO) Other Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Other Accumulated Expenses data on file, last reported at $153.9 million in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 16.86% year-over-year to $153.9 million in Q1 2026; TTM through Mar 2026 was $153.9 million, a 16.86% increase from a year earlier, with the FY2025 full-year figure at $141.7 million, down 3.74% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $153.9 million, up from $141.7 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for BIO reached as high as $212.7 million in Q2 2022 and fell as low as $127.8 million in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $160.0 million across 5 years, with a median of $153.9 million in 2026.
• Across the five-year window, Other Accumulated Expenses soared 371.51% in 2022 and fell 21.85% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $169.6 million in 2022, then fell by 4.74% to $161.6 million in 2023, then decreased by 8.91% to $147.2 million in 2024, then slipped by 3.74% to $141.7 million in 2025, then increased by 8.61% to $153.9 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $153.9 million in Q1 2026, $141.7 million in Q4 2025, and $127.8 million in Q3 2025.